Literature DB >> 18260160

Composite versus individual measures of disease activity in rheumatoid arthritis.

Tuhina Neogi, David T Felson.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18260160

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  6 in total

1.  Peripheral neuropathies: Establishing common clinical research standards for CIDP.

Authors:  Hans-Peter Hartung; Helmar C Lehmann; Hugh J Willison
Journal:  Nat Rev Neurol       Date:  2011-04-12       Impact factor: 42.937

2.  Assessment of hand functions in rheumatoid arthritis using SF-SACRAH (short form score for the assessment and quantification of chronic rheumatoid affections of the hands) and its correlation to disease activity.

Authors:  Harpreet Singh; Suresh Kumar; Paulomi Talapatra; Vikas Gupta; Sucharita Ray; Harish Kumar
Journal:  Rheumatol Int       Date:  2011-11-06       Impact factor: 2.631

3.  Measures of rheumatoid arthritis disease activity in Australian clinical practice.

Authors:  Andrew Taylor; Hanish Bagga
Journal:  ISRN Rheumatol       Date:  2011-05-04

4.  How common is clinically inactive disease in a prospective cohort of patients with juvenile idiopathic arthritis? The importance of definition.

Authors:  Stephanie J W Shoop-Worrall; Suzanne M M Verstappen; Eileen Baildam; Alice Chieng; Joyce Davidson; Helen Foster; Yiannis Ioannou; Flora McErlane; Lucy R Wedderburn; Wendy Thomson; Kimme L Hyrich
Journal:  Ann Rheum Dis       Date:  2017-04-07       Impact factor: 19.103

5.  Real World Experience of Disease Activity in Patients With Rheumatoid Arthritis and Response to Treatment With Varios Biologic DMARDs.

Authors:  Vladimira Boyadzhieva; Nikolay Stoilov; Mariana Ivanova; Guenka Petrova; Rumen Stoilov
Journal:  Front Pharmacol       Date:  2018-11-20       Impact factor: 5.810

6.  Copper bracelets and magnetic wrist straps for rheumatoid arthritis--analgesic and anti-inflammatory effects: a randomised double-blind placebo controlled crossover trial.

Authors:  Stewart J Richmond; Shalmini Gunadasa; Martin Bland; Hugh Macpherson
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.